shopping cart

Confirmation purchase	Item Code	Item Description	Price
	CER3086	Infliximab treatment-induced formation of autoantibodies is common in Behçet’s disease	20.00 €
			Subtotal 20.00 €

© Clinical and Experimental Rheumatology
(Journal with On line Submission)
ISSN n° 1593-098X (electronic)
ISSN n° 0392-856X (print)
VAT IT-00783170509

Social

Help Center

How to register
How to submit an Article
How to review an Article
Contact Us
Authors Guidelines
Visitors Guidelines
Privacy
FAQ

Utilities

Rheumatology acronyms
What's New
Events and Meetings
Links and Banner
Rheuma Comics
Journal

Built with 🧡 by Opera Digitale